Klonidiini (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Klonidiini" in Finnish language version.

refsWebsite

Global rank Finnish rank

4^th place

12^th place

1^st place

2^nd place

10^th place

5^th place

9^th place

8,115^th place

35^th place

low place

165^th place

low place

464^th place

doi.org

Joseph A. Giovannitti, Sean M. Thoms, James J. Crawford: Alpha-2 Adrenergic Receptor Agonists: A Review of Current Clinical Applications. Anesthesia Progress, 2015, nro 1, s. 31–38. PubMed:25849473. doi:10.2344/0003-3006-62.1.31. ISSN 0003-3006. Artikkelin verkkoversio.
Xue Ming, Martha Mulvey, Sharanya Mohanty, Viraj Patel: Safety and efficacy of clonidine and clonidine extended-release in the treatment of children and adolescents with attention deficit and hyperactivity disorders. Adolescent Health, Medicine and Therapeutics, 30.9.2011, nro 2, s. 105–112. PubMed:24600280. doi:10.2147/AHMT.S15672. ISSN 1179-318X. Artikkelin verkkoversio.

Joseph A. Giovannitti, Sean M. Thoms, James J. Crawford: Alpha-2 Adrenergic Receptor Agonists: A Review of Current Clinical Applications. Anesthesia Progress, 2015, nro 1, s. 31–38. PubMed:25849473. doi:10.2344/0003-3006-62.1.31. ISSN 0003-3006. Artikkelin verkkoversio.
Xue Ming, Martha Mulvey, Sharanya Mohanty, Viraj Patel: Safety and efficacy of clonidine and clonidine extended-release in the treatment of children and adolescents with attention deficit and hyperactivity disorders. Adolescent Health, Medicine and Therapeutics, 30.9.2011, nro 2, s. 105–112. PubMed:24600280. doi:10.2147/AHMT.S15672. ISSN 1179-318X. Artikkelin verkkoversio.

Joseph A. Giovannitti, Sean M. Thoms, James J. Crawford: Alpha-2 Adrenergic Receptor Agonists: A Review of Current Clinical Applications. Anesthesia Progress, 2015, nro 1, s. 31–38. PubMed:25849473. doi:10.2344/0003-3006-62.1.31. ISSN 0003-3006. Artikkelin verkkoversio.
Xue Ming, Martha Mulvey, Sharanya Mohanty, Viraj Patel: Safety and efficacy of clonidine and clonidine extended-release in the treatment of children and adolescents with attention deficit and hyperactivity disorders. Adolescent Health, Medicine and Therapeutics, 30.9.2011, nro 2, s. 105–112. PubMed:24600280. doi:10.2147/AHMT.S15672. ISSN 1179-318X. Artikkelin verkkoversio.

Saarelma, Osmo: Tupakoinnin lopettaminen (tupakasta vieroitus) Duodecim – Terveyskirjasto. Arkistoitu 17.3.2018. Viitattu 6.7.2018.
Huttunen, Matti O.: Huumeidenkäytön vieroitushoito Duodecim – Terveyskirjasto. Arkistoitu 6.7.2018. Viitattu 6.7.2018.

VALMISTEYHTEENVETO spc.nam.fi. 9.4.2018. Arkistoitu 6.7.2018.
Saarelma, Osmo: Tupakoinnin lopettaminen (tupakasta vieroitus) Duodecim – Terveyskirjasto. Arkistoitu 17.3.2018. Viitattu 6.7.2018.
Huttunen, Matti O.: Huumeidenkäytön vieroitushoito Duodecim – Terveyskirjasto. Arkistoitu 6.7.2018. Viitattu 6.7.2018.

Joseph A. Giovannitti, Sean M. Thoms, James J. Crawford: Alpha-2 Adrenergic Receptor Agonists: A Review of Current Clinical Applications. Anesthesia Progress, 2015, nro 1, s. 31–38. PubMed:25849473. doi:10.2344/0003-3006-62.1.31. ISSN 0003-3006. Artikkelin verkkoversio.
Xue Ming, Martha Mulvey, Sharanya Mohanty, Viraj Patel: Safety and efficacy of clonidine and clonidine extended-release in the treatment of children and adolescents with attention deficit and hyperactivity disorders. Adolescent Health, Medicine and Therapeutics, 30.9.2011, nro 2, s. 105–112. PubMed:24600280. doi:10.2147/AHMT.S15672. ISSN 1179-318X. Artikkelin verkkoversio.